Dr. Dragana Lovre joined the Section of Endocrinology after completing her Endocrinology Fellowship at Tulane University School of Medicine in 2016. Dr. Lovre received her bachelor’s degree in chemistry from Baldwin-Wallace University in Cleveland, Ohio. She then worked at Case Western Reserve University on NIH Developmental Research projects prior to starting medical school. Dr. Lovre is board certified in Internal Medicine and trained at LJ Chabert Medical Center in Houma, Louisiana. Her clinical and research interests focus on cardiovascular complications of diabetes with special interest women’s health. Dr. Lovre is currently involved in multiple trials on estrogen effect on glucose homeostasis and cardiovascular complications of diabetes.
Publications & Presentations
- Lovre D, Fonseca V. Benefits of timely basal insulin control in patients with type 2 diabetes. J Diabetes Complications. 2015 Mar;29(2):295-301. doi: 10.1016/j.jdiacomp.2014.11.018. Epub 2014 Dec 5. Review. PMID: 25536866
- Lovre D, Lindsey SH, Mauvais-Jarvis F. Effect of menopausal hormone therapy on components of the metabolic syndrome. Ther Adv Cardiovasc Dis. 2016 May 27. pii: 1753944716649358. [Epub ahead of print] Review. PMID: 27234158
- Lovre D, Mauvais-Jarvis F. Trends in Prevalence of the Metabolic Syndrome. JAMA. 2015 Sep 1;314(9):950. doi: 10.1001/jama.2015.8625. PMID: 26325567
- Xu B, Lovre D, Mauvais-Jarvis F. Effect of selective estrogen receptor modulators on metabolic homeostasis. Biochimie. 2016 May;124:92-7. doi: 10.1016/j.biochi.2015.06.018. Epub 2015 Jun 29. Review. PMID: 26133657
- Lovre D, Htun W, Carrion C, Fonseca VA. What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents? Curr Diab Rep. 2016 Oct;16(10):94. doi: 10.1007/s11892-016-0788-5. Review. PMID: 27541296
Further publications listed in PubMed: https://www.ncbi.nlm.nih.gov/pubmed/?term=Lovre%2C+Dragana